Drug
Focal Radiation Therapy
Focal Radiation Therapy: highest development phase Phase 2, developed by United Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- United Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Focal Radiation therapy NCT03804944 | Phase 2 | Breast Cancer |
Latest
No recent events.
Follow Focal Radiation Therapy on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.